GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GeneOne Life Science Inc (XKRX:011000) » Definitions » Interest Expense

GeneOne Life Science (XKRX:011000) Interest Expense : ₩-2,629 Mil (TTM As of Dec. 2023)


View and export this data going back to 1987. Start your Free Trial

What is GeneOne Life Science Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. GeneOne Life Science's interest expense for the three months ended in Dec. 2023 was ₩ -264 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was ₩-2,629 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. GeneOne Life Science's Operating Income for the three months ended in Dec. 2023 was ₩ -11,276 Mil. GeneOne Life Science's Interest Expense for the three months ended in Dec. 2023 was ₩ -264 Mil. GeneOne Life Science did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


GeneOne Life Science Interest Expense Historical Data

The historical data trend for GeneOne Life Science's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GeneOne Life Science Interest Expense Chart

GeneOne Life Science Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1,967.10 -628.50 -4,454.95 -7,309.29 -1,179.63

GeneOne Life Science Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -706.48 -2,145.12 -146.67 -73.44 -263.86

GeneOne Life Science Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-2,629 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


GeneOne Life Science  (XKRX:011000) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

GeneOne Life Science's Interest Expense for the three months ended in Dec. 2023 was ₩-264 Mil. Its Operating Income for the three months ended in Dec. 2023 was ₩-11,276 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2023 was ₩12,358 Mil.

GeneOne Life Science's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

GeneOne Life Science did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.


GeneOne Life Science (XKRX:011000) Business Description

Traded in Other Exchanges
N/A
Address
343, Hakdong-ro, Gangnam-Gu, Seoul, KOR
GeneOne Life Science Inc is engaged in the research, development, and manufacturing of biopharmaceutical products including vaccines for treating pandemic influenza, seasonal influenza for old people, and chronic hepatitis B and C as well cancers and other infectious diseases.

GeneOne Life Science (XKRX:011000) Headlines

No Headlines